Sanofi unit gets 40 brands, 750 Indian staffers in buyout

Sanofi ($SNY) and United Medicare agreed on a buyout deal that would give the French drugmaker's Indian unit Aventis Pharma 40 over-the-counter nutraceutical brands and 750 of Universal Medicare's employees. The acquisition will allow Sanofi to reach "large sections of India's population through...pharmaceuticals, vaccines and now nutraceuticals," Aventis managing director Shailes Ayyangar said. Report

Suggested Articles

Several of the industry's top players had a strong performance in the fourth quarter, growing revenues at high single digits. Others? Not so much.

Viatris, the merger of Mylan and Pfizer's Upjohn, has fleshed out its board and C-suite with a raft of Pfizer and Mylan veterans.

An FDA approval of Lilly’s Cyramza combo would pit it against AZ's Tagrisso, which has charted impressive survival gains in EGFR-positive lung cancer.